Friday 6 November 2026
Export SFES’s income statement to Excel — free account
Safeguard Scientifics, Inc.
SFES Financial Asset Management
- EPS
- −121.7%
- Free cash flow
- +42.7%
Quarter to June 2026, against a year earlier
0.60
0.02
+3.45%
Follow SFES
Alert me
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to December
| Ten-year view | Analyst estimates Powerpack | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Group | Line | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM Jun ’26 | Trend | 10 yrs | 2026e | 2027e | 2028e | Next 3/yr |
| Income, $m | ||||||||||||||||||
| Income, $m | Revenue | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Gross margin, % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | 0.0 pt | ||||||
| EBT | (22) | (89) | (16) | 55 | (38) | 27 | (14) | (10) | (10) | 2 | 19 | n/m | ||||||
| EBT margin, % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.0 pt | ||||||
| Net income | (22) | (89) | (16) | 55 | (38) | 27 | (14) | (10) | (10) | 2 | 2 | n/m | ||||||
| Per share, $ | ||||||||||||||||||
| Per share, $ | Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | n/m | |||||
| Earnings | (1.09) | (4.34) | (0.76) | 2.64 | (1.81) | 1.36 | (0.87) | (0.61) | (0.62) | 0.10 | 1.16 | n/m | ||||||
| Cash flow | (0.92) | (1.02) | (1.27) | (0.97) | (0.39) | (0.41) | (0.20) | (0.20) | (0.18) | (0.11) | (0.08) | (21.3%) | ||||||
| Capex | (0.02) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | n/m | ||||||
| Free cash flow | (0.94) | (1.02) | (1.27) | (0.97) | (0.39) | (0.41) | (0.20) | (0.20) | (0.17) | (0.11) | (0.08) | (21.5%) | ||||||
| Book value | 8.35 | 4.00 | 3.26 | 4.93 | 3.03 | 2.55 | 2.12 | 1.23 | 0.59 | 0.69 | 0.37 | (24.2%) | ||||||
| Shares, m | 20 | 20 | 21 | 21 | 21 | 20 | 16 | 16 | 17 | 17 | 17 | (2.2%) | ||||||
| Valuation, × | ||||||||||||||||||
| Valuation, × | P/E | — | — | — | — | — | — | — | — | — | — | 0 | — | |||||
| P/S | — | — | — | — | — | — | — | — | — | — | 0 | — | ||||||
| P/B | — | — | — | — | — | — | — | — | — | — | 0 | — | ||||||
| EV/Sales | — | — | — | — | — | — | — | — | — | — | — | — | ||||||
| EV/FCF | — | — | — | — | — | — | — | — | — | — | — | — | ||||||
| Cash, $m | ||||||||||||||||||
| Cash, $m | Operating cash flow | (19) | (21) | (26) | (20) | (8) | (8) | (3) | (3) | (3) | (2) | (1) | (23.0%) | |||||
| Capex | 0 | — | 0 | — | — | — | — | — | 0 | — | 0 | n/m | ||||||
| Free cash flow | (19) | (21) | (26) | (20) | (8) | (8) | (3) | (3) | (3) | (2) | (1) | (23.2%) | ||||||
| Balance, $m | ||||||||||||||||||
| Balance, $m | Working capital | 27 | (12) | 14 | 24 | 13 | 29 | 20 | 8 | 6 | 8 | 4 | (12.2%) | |||||
| Net debt | 22 | 57 | 24 | (25) | (16) | (25) | (19) | (10) | (7) | (9) | (5) | n/m | ||||||
| Shareholders’ equity | 170 | 82 | 67 | 102 | 63 | 51 | 35 | 20 | 10 | 12 | 6 | (25.8%) | ||||||
| Returns, % | ||||||||||||||||||
| Returns, % | ROA | (9.11) | (43.39) | (9.70) | 43.08 | (42.60) | 43.89 | (31.10) | (32.47) | (60.84) | 14.48 | 214.23 | +23.6 pt | |||||
| ROIC | (6.09) | (7.72) | (11.59) | (8.14) | (12.51) | (17.33) | (19.55) | (33.95) | (54.53) | (50.98) | (84.13) | (44.9) pt | ||||||
| ROE | (12.19) | (70.41) | (21.01) | 64.68 | (45.70) | 47.61 | (33.50) | (36.03) | (69.68) | 16.14 | 237.38 | +28.3 pt | ||||||
| People | ||||||||||||||||||
| People | Employees | 33 | 33 | — | — | — | — | — | — | — | — | — | 0.0% | |||||
| Revenue/emp, $m | 0.00 | 0.00 | — | — | — | — | — | — | — | — | — | n/m | ||||||
Negative figures in brackets.
estimates
Fiscal years to Dec 2009 · latest quarter Dec 2009 · fundamentals updated 25 Oct 2026
Safeguard Scientifics, Inc. vs peers in Asset Management (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| INV Innventure, Inc. | $13.7M | — (loss-making) | — | +100.21% (above 0%: growing) | n/m | −16.26% (below 0%: shrinking) | (432.32%) | (3,304.09%) | Compare |
| BENF Beneficient | $13.2M | — (loss-making) | — (loss-making) | +196.37% (above 0%: growing) | n/m | +62.45% (above 0%: growing) | 100.00% | 34.47% | Compare |
| AMTD AMTD IDEA Group | $11.0M | 11.0× | — (loss-making) | +90.59% (above 0%: growing) | −31.02% (below 0%: shrinking) | — | 0.00% | 0.00% | Compare |
| EQS Equus Total Return, Inc. | $8.9M | — (loss-making) | 32.9× | −10.92% (below 0%: shrinking) | n/m | +113.19% (above 0%: growing) | 100.00% | (266.98%) | Compare |
| ICMB Investcorp Credit Management BDC, Inc. | $8.8M | — (loss-making) | 20.5× | −31.05% (below 0%: shrinking) | n/m | +238.07% (above 0%: growing) | 100.00% | 59.40% | Compare |
| SFES Safeguard Scientifics, Inc. | $7.5M | 0.5× | — | — | n/m | +42.68% (above 0%: growing) | 0.00% | 0.00% | |
| TWAV TaoWeave, Inc. | $4.8M | — (loss-making) | 12.4× | −11.82% (below 0%: shrinking) | n/m | +107.53% (above 0%: growing) | 52.49% | (161.11%) | Compare |
| ALP Alpha Compute Corp | $4.6M | — (loss-making) | — (loss-making) | — | n/m | +66.68% (above 0%: growing) | 0.00% | 0.00% | Compare |
| CWD CaliberCos Inc. | $4.3M | — (loss-making) | — (loss-making) | −17.33% (below 0%: shrinking) | n/m | −126.92% (below 0%: shrinking) | 100.00% | (98.97%) | Compare |
| Median of peers | $8.9M | — | 20.5× | −10.92% | — | +66.68% | 76.25% | (49.48%) |
Pay and ownership Proxy statement filed 2 November 2023
Ownership
Directors and executive officers, together
9.70%
Thomas A. Satterfield, Jr.
12.60%
Contrarian Capital Management, L.L.C.
7.20%
First Manhattan Co.
7.20%
Yakira Partners, L.P., Yakira Enhanced Offshore Fund Ltd. and MAP
7.00%
Ownership is the proxy’s own table: the directors and officers as a group, and every holder of 5% or more.
Read the proxy statement